Cargando…
Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic Microangiopathy
In patients with pregnancy-associated complement gene variant–mediated thrombotic microangiopathy (cTMA), terminal complement blockade is used for treatment of cTMA flares during pregnancy or following delivery. We report pregnancy and delivery outcomes of 2 genetically high-risk patients with cTMA,...
Autores principales: | Haninger-Vacariu, Natalja, Aigner, Christof, Kain, Renate, Prohászka, Zoltán, Gaggl, Martina, Böhmig, Georg A., Piggott, Leah Charlotte, Sunder-Plassmann, Raute, Sunder-Plassmann, Gere, Schmidt, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380370/ https://www.ncbi.nlm.nih.gov/pubmed/32734241 http://dx.doi.org/10.1016/j.xkme.2019.12.004 |
Ejemplares similares
-
Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2020) -
Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2023) -
Sex Differences in Clinical Presentation and Outcomes among Patients with Complement-Gene-Variant-Mediated Thrombotic Microangiopathy
por: Aigner, Christof, et al.
Publicado: (2020) -
Eculizumab use in a tertiary care nephrology center: data from the Vienna TMA cohort
por: Aigner, Christof, et al.
Publicado: (2021) -
Complement-Mediated Thrombotic Microangiopathy Related to COVID-19 or SARS-CoV-2 Vaccination
por: Aigner, Christof, et al.
Publicado: (2023)